‹ All Posts
Unite Technologies Financial

28th Jul · SEBI-Registered Analyst

Technical Analysis Dr. Agarwal's Health Care

The stock $AGARWALEYE is trading in a sideways-to-positive trend after recovering from its March-April correction. Over the last few weeks it has been consolidating between ₹475 and ₹500 showing that buyers are gradually returning but a decisive breakout is still pending. The chart shows higher lows from the April bottom indicating improving momentum. However repeated rejection near the ₹500 zone suggests that sellers are still active at higher levels. A strong close above this resistance could trigger the next uptrend. The stock has immediate support around ₹475-480 where buyers have repeatedly stepped in. A break below this zone could push the price toward ₹450-455. On the upside ₹500 is the key resistance. If the stock closes above this level with strong volume it may move towards ₹520-540. The outlook remains cautiously bullish as long as the stock holds above ₹475. Existing investors can continue to hold while fresh buying is better considered only after a confirmed breakout above ₹500 with good trading volume. The recent price action indicates accumulation rather than distribution.

#MacroViews#TechnicalViews#EquityResearch#WatchOutFor
717 likes·49 comments